These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30328750)

  • 21. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
    Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
    Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
    Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GFI1 is required for
    Marneth AE; Botezatu L; Hönes JM; Israël JCL; Schütte J; Vassen L; Lams RF; Bergevoet SM; Groothuis L; Mandoli A; Martens JHA; Huls G; Jansen JH; Dührsen U; Berg T; Möröy T; Wichmann C; Lo MC; Zhang DE; van der Reijden BA; Khandanpour C
    Haematologica; 2018 Sep; 103(9):e395-e399. PubMed ID: 29674496
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correlations Between
    Wang XM; Ye YX; Yang L; Lu XJ; Ying BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):931-935. PubMed ID: 28598127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.
    Di Genua C; Norfo R; Rodriguez-Meira A; Wen WX; Drissen R; Booth CAG; Povinelli B; Repapi E; Gray N; Carrelha J; Kettyle LM; Jamieson L; Neo WH; Thongjuea S; Nerlov C; Mead AJ
    Haematologica; 2019 Nov; 104(11):2215-2224. PubMed ID: 30975913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway.
    Li Y; Gao L; Luo X; Wang L; Gao X; Wang W; Sun J; Dou L; Li J; Xu C; Wang L; Zhou M; Jiang M; Zhou J; Caligiuri MA; Nervi C; Bloomfield CD; Marcucci G; Yu L
    Blood; 2013 Jan; 121(3):499-509. PubMed ID: 23223432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
    Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
    J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of AML1-ETO Positive Acute Myeloid Leukemia Morphologically Similar to Chronic Myelogenous Leukemia.
    Li R; Wu Y; Zhang X; LihuaWang ; Huo S
    Clin Lab; 2023 May; 69(5):. PubMed ID: 37145071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
    Yang E; Guan W; Gong D; Gao X; Han C; Zhang J; Wang H; Wang M; Li Y; Yu L
    Clin Sci (Lond); 2020 Dec; 134(23):3079-3091. PubMed ID: 33201243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AML1-ETO inhibits acute myeloid leukemia immune escape by CD48.
    Wang Z; Guan W; Wang M; Chen J; Zhang L; Xiao Y; Wang L; Li Y; Yu L
    Leuk Lymphoma; 2021 Apr; 62(4):937-943. PubMed ID: 33225787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three way translocation in a new variant of t(8;21) acute myeloid leukemia involving Xp22.
    Vundinti BR; Kerketta L; Madkaikar M; Jijina F; Ghosh K
    Indian J Cancer; 2008; 45(1):30-2. PubMed ID: 18453738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myeloid leukemia (aml) subtype M2 with variation of the t (8;21)translocation and AML1/ETO expression].
    Llimpe Y; Monteza R; Ticlahuanca J; Rubio P; Ortíz C; Arias A
    Rev Peru Med Exp Salud Publica; 2013 Mar; 30(1):145-6. PubMed ID: 23612831
    [No Abstract]   [Full Text] [Related]  

  • 34. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
    Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H
    Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
    Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
    Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Co-existence of AML1-ETO and BCR-ABL1 fusion genes in acute myeloid leukemia: a case report].
    Yao YQ; Jia X; Liu H; Lu QS; Xiong WJ; Zhang Y; Liu QF; Shi PC
    Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):203-206. PubMed ID: 38326048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3.
    Liu Y; Zheng L; Li Y; Ma L; Zheng N; Liu X; Zhao Y; Yu L; Liu N; Liu S; Zhang K; Zhou J; Wei M; Yang C; Yang G
    Cancer Lett; 2024 Jul; 594():216980. PubMed ID: 38797229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Transcriptome Study of Subtype M2 Acute Myeloblastic Leukemia.
    Wu AY; Yang HC; Lin CM; Wu BD; Qu QS; Zheng YH; Wei H; Mei XQ; Zeng ZH; Ma XD
    Cell Biochem Biophys; 2015 Jul; 72(3):653-6. PubMed ID: 27352183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.
    Maiques-Diaz A; Chou FS; Wunderlich M; Gómez-López G; Jacinto FV; Rodriguez-Perales S; Larrayoz MJ; Calasanz MJ; Mulloy JC; Cigudosa JC; Alvarez S
    Leukemia; 2012 Jun; 26(6):1329-37. PubMed ID: 22289984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
    Rejeski K; Duque-Afonso J; Lübbert M
    Oncogene; 2021 Sep; 40(38):5665-5676. PubMed ID: 34331016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.